Send feedback

ACADVL p.Ser231=

c.693T>A · rs77763289 · VCV136261

Benign Expert panel
Classification
Benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 10 submitters
gnomAD v4.1
Rare
low-frequency (popmax 2%, afr)
Conditions
1
very long chain acyl-CoA dehydrogenase deficiency

ClinGen expert panel — ACADVL VCEP

Benign for very long chain acyl-CoA dehydrogenase deficiency. Applied ACMG criteria (verbatim):

BP7 BP4 BA1

Curation rationale (ClinGen, verbatim)

The NM_000018.4(ACADVL):c.693T>A (p.Ser231=) variant is a synonymous (silent) variant that is not predicted by SpliceAI and NNSplice to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by PhyloP and PhastCons (BP4, BP7). The highest population minor allele frequency in gnomAD v2.1.1 is 0.2061 in the African/African American population, which is higher than the ClinGen ACADVL Variant Curation Expert Panel threshold (≥0.007) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as benign for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: BA1, BP4 (ACADVL VCEP specifications version 1; approved November 9, 2021).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -2.1GERP -4.2
Overall
CADD1.916PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 2% African / African-American · 1,502/75,014 alleles
Filtering AF 1.92% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.88%
Overall 0.127% 2,053/1,614,146 alleles · low-frequency
Ancestry group Frequency 1 in
African / African-Americangrpmax 2% 50
Middle Eastern 0.561% 178
Admixed American 0.272% 368
Remaining individualsnot grpmax-eligible 0.163% 613
Finnishnot grpmax-eligible 0.0906% 1,104
European (non-Finnish) 0.0161% 6,211
South Asian 0.00439% 22,771

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ACADVL
Protein
p.Ser231=
Coding
c.693T>A
MANE Select
NM_000018
dbSNP
rs77763289
Type
single nucleotide variant
Location
chr17:7222022 (GRCh38)
Gene constraint
LOEUF 1.077 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 90.65 · 3 PDB
Residue 231
a β-strand; the 'catalytic' region
Full ACADVL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

very long chain acyl-CoA dehydrogenase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Very long chain acyl-CoA dehydrogenase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal
Prevalence
1-9 / 100 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/acadvl-p-ser231 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown